GlassScriptPhysician profile
Benjamin J Cohen
NPI 1114991767
$8,876.47
in general payments reported to CMS, 2019-2025
37 companies · $802 in 2025
The $802 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,185 · 2020: $464 · 2021: $1,558 · 2022: $1,904 · 2023: $2,059 · 2024: $905 · 2025: $802.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,755 · Education: $10.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,754.65 |
| Education | $10.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,168.39 | 2019-2025 | |
| Heartflow, INC. | $713.50 | 2022-2025 | Ffrct |
| Medtronic, INC. | $649.21 | 2021-2025 | Corevalve Evolut R, Micra, Reveal Linq |
| Boston Scientific Corporation | $599.52 | 2019-2025 | General - Pain Management, Watchman Access System, Varithena Administration Pack |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $546.10 | 2019-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $492.85 | 2019-2024 | Camzyos, Eliquis |
| Amgen INC. | $456.63 | 2019-2024 | Repatha |
| Medtronic Vascular, INC. | $431.57 | 2019-2020 | |
| Abbott Laboratories | $429.04 | 2019-2025 | Aveir |
| Pfizer INC. | $388.52 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $380.66 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $346.92 | 2021-2024 | Verquvo |
| Sanofi-Aventis U.S. LLC | $339.72 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $300.81 | 2020-2025 | Jardiance |
| Amarin Pharma, INC. | $281.62 | 2019-2023 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.